Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Pharmacy
Published in: International Journal of Clinical Pharmacy 2/2020

01-04-2020 | Care | Commentary

Ambulatory care pharmacy practice in China: status and future efforts

Authors: Lu Zhang, Yamin Huang, Xingxing Huang, Keke Liu, Yangyong Yu, Shusen Sun, Jian Xiao

Published in: International Journal of Clinical Pharmacy | Issue 2/2020

Login to get access

Abstract

In recent years, as the era of deepening healthcare reform in China progresses, there is a gradual development of ambulatory care pharmacy practice. This commentary reviews the current state of ambulatory care pharmacy practice in China and discusses future efforts to advance the practice. Areas of focus include practice standardization, transitions of care, and reimbursements of ambulatory care pharmacy practice.
Literature
1.
YI Z, Sun S, LI X, Lu M, Zhai S. An evaluation of clinical pharmacist service on a neurology care unit. Int J Clin Pharm. 2016;38(1):30–3.PubMedCrossRef
2.
Wang Z, Mao Z, Li T, Du W. Policy effectiveness analysis of pilot reform in centralized drug purchasing: case study of Sanming City, Fujian Province. Chin J Health Policy. 2017;8(1):21–6.
3.
Yang J, Meng L, Liu Y, Lv L, Sun S, Long R, et al. Drug-related problems among community-dwelling older adults in mainland China. Int J Clin Pharm. 2018;40(2):368–75.PubMedCrossRef
4.
National Health Commission of the People’s Republic of China. Notice on Strengthening the Pharmaceutical Administration and Changing the Mode of Pharmaceutical Services. https://​www.​nhc.​gov.​cn/​. Accessed 5 January 2019.
5.
Zhang J, Liu M, Chen Q, Wu J, Cao H. Outcomes of an online pharmacist-managed anticoagulation clinic for individuals on warfarin therapy living in rural communities. Thromb Res. 2017;157:136–8.PubMedCrossRef
6.
Li X, Sun S, Wang Q, Chen B, Zhao Z, Xu X. Assessment of patients’ warfarin knowledge and anticoagulation control at a joint physician- and pharmacist-managed clinic in China. Patient Prefer Adher. 2018;12:783–91.PubMedPubMedCentralCrossRef
7.
Sachdev GP. Ambulatory care pharmacist services: the value proposition. Am J Health Syst Pharm. 2018; 75(21):1688–9.CrossRef
8.
Buxton JA, Babbitt R, Clegg CA, Durley SF, Epplen KT, Marsden LM, et al. ASHP guidelines: minimum standard for ambulatory care pharmacy practice. Am J Health Syst Pharm. 2016;72(14):1221–366.CrossRef
9.
Guangdong Pharmaceutical Association. The trial standards of ambulatory care pharmacy practice. Pharmacy Today. 2018;11:721–6.
10.
11.
Koehler BE, Richter KM, Youngblood L, Cohen BA, Prengler ID, Cheng D, et al. Reduction of 30-day postdischarge hospital readmission or emergency department (ED) visit rates in high-risk elderly medical patients through delivery of a targeted care bundle. J Hosp Med. 2009;4(4):211–8.PubMedCrossRef
12.
Schnipper JL, Kirwin JL, Cotugno MC, Wahlstrom SA, Brown BA, Tarvin E, et al. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med. 2006;166(5):565–71.PubMedCrossRef
13.
Ni W, Colayco D, Hashimoto J, Komoto K, Gowda C, Wearda B, et al. Reduction of healthcare costs through a transitions-of-care program. Am J Health Syst Pharm. 2018;75(10):613–21.PubMedCrossRef
14.
Ensing HT, Stuijt CC, van den Bemt BJ, van Dooren AA, Karapinar-Çarkit F, Koster ES, et al. Identifying the optimal role for pharmacists in care transitions: a systematic review. J Manag Care Spec Pharm. 2015;21(8):614–36.PubMed
15.
16.
Houle SK, Grindrod KA, Chatterley T, Tsuyuki RT. Paying pharmacists for patient care: a systematic review of remunerated pharmacy clinical care services. Can Pharm J (Ott). 2014;147(4):209–32.PubMedCentralCrossRef
17.
Xu G. Analysis of pharmacy service fee in community pharmacies under the background of separation of medicine and pharmacy. Chin Pharm Affairs. 2018;32(11):1462–6.
18.
The Consensus Chinese Pharmacy Service Standards and Charges of Experts. Drug Eval. (Chinese). 2016;13(14):8–15.
Metadata
Title
Ambulatory care pharmacy practice in China: status and future efforts
Authors
Lu Zhang
Yamin Huang
Xingxing Huang
Keke Liu
Yangyong Yu
Shusen Sun
Jian Xiao
Publication date
01-04-2020
Publisher
Springer International Publishing
Keyword
Care
Published in
International Journal of Clinical Pharmacy / Issue 2/2020
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-020-00998-2

Other articles of this Issue 2/2020

International Journal of Clinical Pharmacy 2/2020 Go to the issue

Research Article

Improving patient safety through a pharmacist-led medication reconciliation programme in nursing homes for the elderly in Spain

Research Article

Quality assessment and cost saving of renal dosing recommendation by clinical pharmacists at medical wards in Thailand

Research Article

Comparison of drug survival between infliximab and adalimumab in inflammatory bowel disease

Research Article

Development and psychometric evaluation of the patient’s HIV knowledge questionnaire (PHKQ)

Commentary

Providing pharmacy services at cabin hospitals at the coronavirus epicenter in China

Short Research Report

Hypothalamic–pituitary–adrenal axis suppression by inhaled or nasal corticosteroids in HIV-infected patients
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits